ApoB was degraded by the proteasome in a ubiquitin-independent manner in Huh-7 cells. by Bei Wang (116772)

TM9SF4 decreases during vitamin D3-induced Mo differentiation of U937 cells, but increases during ATRA-induced G differentiation of HL-60 cells. by Rosa Paolillo (736953)

Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms by Andrea Corsello (5172026)

“…</p><p>Methods</p><p>In the attempt to identify a more reliable biomarker for NENs, we investigated, by ELISA, the circulating levels of full-length CgA (CgA_1-439) and of various CgA-derived fragments in 17 patients with ileal or pancreatic NENs, 10 healthy controls, and 21 healthy volunteers before and after treatment with PPIs.…”

ICAM-1 and VCAM-1 in the parietal peritoneum. by Paulina M. Kowalewska (625078)

“…Data recorded as mean ± SEM and analyzed with ANOVA with Bonferroni correction, 4 venules averaged per mouse, <i>n</i> = 4–5 mice, ∧<i>p</i><0.05 compared with isotype control. …”

(color online) <i>p</i> = 0.5, <i>s</i> = 1.2. by Yibin Kang (250165)

Characteristics of stillborn calves measured in post-foraging necropsies. by Marian L. Wahl (19421877)

Angiogenic role of miR-20a in breast cancer by Gines Luengo-Gil (5059052)

“…A higher miR-20a expression was associated with higher mean vessel size (<i>p</i> = 0.015) and with an angiogenic pattern consisting in larger vessels, higher VEGFA expression and presence of glomeruloid microvascular proliferations (<i>p</i><0.001). …”

RNAi-based screen for genes that modify aSyn oligomerization in living cells. by Susana A. Gonçalves (199613)

“…</b> Representative live cell imaging pictures of aSyn-BiFC stable H4 cells silenced for hits that increase (<i>RAB8B</i>, <i>RAB11A</i>, <i>RAB13</i>, <i>RAB39B</i>, <i>CAMK1</i>, <i>DYRK2</i>) or decrease (<i>CC2D1A</i>, <i>CLK4</i>, <i>SYTL5)</i> aSyn oligomerization (green). …”

Increased histone acetylation, and decreased global transcription and histone H3K4 methylation in <i>Hdac1^−/+/Hdac2^−/−</i> growing oocytes. by Pengpeng Ma (389371)

PKC, NFκB, and iNOS mediate the effect of AngII on LPL expression in VAT. by Tsuyoshi Uchiyama (201495)

Transfluthrin repellency depends on its action on voltage-gated sodium channels. by Felipe Andreazza (11098928)

Figure S2: Depletion of RASSF1A alone or with RASSF1C results in disappearance of tight junctions and decrease of adherens junction, replaced by diffuse adherent junctions. from RA... by Fatéméh Dubois (5846192)

Synthesis and visualisation of prior brain imaging and stimulation results involving reaching. by Aoife M. Fitzpatrick (13955365)

Mechanistic Interrogation of a PQQ and Rare Earth-Dependent Artificial Metalloenzyme by Mohd Taher (22385539)

“…Preparing ArMs with metal ions spanning the rare earth series, we observed decreasing reactivity with increasing Lewis acidity, a pattern consistent with that of natural ADH assays. …”

Mechanistic Interrogation of a PQQ and Rare Earth-Dependent Artificial Metalloenzyme by Mohd Taher (22385539)

“…Preparing ArMs with metal ions spanning the rare earth series, we observed decreasing reactivity with increasing Lewis acidity, a pattern consistent with that of natural ADH assays. …”

Mechanistic Interrogation of a PQQ and Rare Earth-Dependent Artificial Metalloenzyme by Mohd Taher (22385539)

“…Preparing ArMs with metal ions spanning the rare earth series, we observed decreasing reactivity with increasing Lewis acidity, a pattern consistent with that of natural ADH assays. …”

DataSheet1_Oxidized low density lipoprotein in the liver causes decreased permeability of liver lymphatic- but not liver sinusoidal-endothelial cells via VEGFR-3 regulation of VE-C... by Alyssa R. Goldberg (13979865)

“…Utilizing an in vitro permeability assay, we found that oxLDL decreased the permeability of lymphatic endothelial cells (LEC)s, but not liver sinusoidal endothelial cells (LSEC)s. …”

Frequency of message feature use, pre- versus post- emergency declaration. by Jeannette Sutton (785904)

Effect of glucagon 200ng/kg on hepatic and plasma NO content. by Rita S. Patarrão (737406)

Varying dose. by Brenda Lyn A. Gavina (15285185)